The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Infectious Disease Diagnostics Testing Market During 2026–2030?
The infectious disease diagnostics testing market has experienced rapid expansion recently. Projections indicate a rise from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. Historically, this growth stemmed from factors such as the increasing prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, greater awareness of early disease diagnosis, and enhanced government focus on disease control.
The infectious disease diagnostics testing market is set to experience significant expansion over the next few years. It is forecast to reach $65.49 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.0%. This projected growth can be ascribed to several factors, including the increasing threat of global pandemics, a heightened need for rapid diagnostic solutions, rising investments in healthcare diagnostics, the expansion of disease surveillance programs, and the increasing burden of tropical and viral diseases. Prominent trends throughout this forecast period encompass an escalating demand for prompt and early infectious disease detection, the growing adoption of point-of-care infectious disease tests, an increased reliance on molecular diagnostics for pathogen identification, the broadening scope of diagnostic testing for emerging and re-emerging infections, and an intensified focus on large-scale disease screening and surveillance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
What Primary Drivers Are Shaping The Infectious Disease Diagnostics Testing Market?
The future expansion of the infectious disease diagnostic testing market is anticipated to be driven by an increase in respiratory infections. These infections affect the respiratory system, encompassing the nose, throat, airways, and lungs. The growing number of respiratory infections is attributed to viral and bacterial transmission through close contact with infected individuals, suboptimal hygiene, crowded living conditions, and fluctuating seasonal weather patterns. Infectious disease diagnostic testing is crucial for diagnosing and treating respiratory infections because it can precisely identify pathogens such as bacteria and viruses in patient samples. For instance, in February 2024, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, hospitalizations for acute upper respiratory infections increased by 32% from 2,114 in 2022 to 2,797 cases in 2023. Consequently, the rise in respiratory infections is stimulating the infectious disease diagnostic testing market.
How Is The Infectious Disease Diagnostics Testing Market Broken Down By Segment Categories?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
What Trends Are Affecting The Growth Of The Infectious Disease Diagnostics Testing Market?
Leading companies in the infectious disease diagnostic testing market are advancing innovative technologies for the rapid and reliable identification of critical infections. Infectious disease diagnostics focuses on pinpointing pathogens, such as bacteria, viruses, or parasites, which is essential for guiding diagnosis and treatment. For instance, in January 2025, QIAGEN, a Germany-based biotechnology company, introduced new QIAstat-Dx syndromic testing panels in India, specifically the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, which were launched alongside the previously authorized Respiratory SARS-CoV-2 Panel, all approved by India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system employs multiplex real-time PCR with single-use cartridges to detect multiple pathogens concurrently, providing results in approximately an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy when compared to traditional methods, thereby enabling timely treatment, enhancing patient outcomes, and alleviating burdens on healthcare systems. The system also features configurable setups and cloud connectivity, facilitating remote monitoring and efficient data management.
Which Players Are Present In The Infectious Disease Diagnostics Testing Market Space?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC
Get The Full Infectious Disease Diagnostics Testing Market Report:
Which Region Has The Greatest Market Share In The Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Infectious Disease Diagnostics Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company
Disposable Incontinence Products Market Report 2026
Urinary Incontinence Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model